Inventor · disambiguated record
Yu-Ju G. Meng
Also filed as: MENG YU-JU G · MENG YU-JU GLORIA
7 granted patents·25 pending applications·111 citations·filing 1999–2020
82Inventor score
Top patents by PatentIndex Score
32 records- 0187US6927024B2PCR assayGENENTECH INC·Filed 1999·Granted Aug 9, 2005·95 cites·60 claims
- 0285US8449885B2Anti-VEGF antibodiesMENG YU-JU G·Filed 2010·Granted May 28, 2013·11 cites·3 claims
- 0379US10662254B2Hinge modified antibody fragments and methods of makingGENENTECH INC·Filed 2018·Granted May 26, 2020·2 cites·10 claims
- 0475US8771685B2Anti-BV8 antibodies and uses thereofWU XIUMIN·Filed 2010·Granted Jul 8, 2014·3 cites·6 claims
- 0563US2010098730A1Immunoglobulin variants and uses thereofLOWMAN HENRY B·Filed 2009·Application pending·0 cites
- 0663US2013336960A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0763US2014017231A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0863US2014017232A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0963US2013336959A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1063US2014193397A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1163US2014056874A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1263US2014056875A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1363US2013344059A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1463US2014023639A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1562US2021002359A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 1660US2014294810A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 1759US2017276683A1Elisa for vegfGENENTECH INC·Filed 2017·Application pending·0 cites
- 1857US2005005310A1Expression vectors and methodsGENENTECH INC·Filed 2003·Application pending·0 cites
- 1956US9625462B2Elisa for VEGFGENENTECH INC·Filed 2015·Granted Apr 18, 2017·0 cites·15 claims
- 2056US2006062727A1Compositions and methods for the diagnosis and treatment of tumorPHILIPS HEIDI S·Filed 2003·Application pending·0 cites
- 2154US9266948B2Anti-Bv8 antibodies and uses thereofGENENTECH INC·Filed 2014·Granted Feb 23, 2016·0 cites·8 claims
- 2254US2020308304A1Hinge modified antibody fragments and methods of makingGENENTECH INC·Filed 2020·Application pending·0 cites
- 2353US9146245B2ELISA for VEGFMENG YU-JU G·Filed 2012·Granted Sep 29, 2015·0 cites·13 claims
- 2453US2009181014A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2006·Application pending·0 cites
- 2552US2008227119A1ELISA for VEGFGENENTECH INC·Filed 2007·Application pending·0 cites
- 2652US2007054303A1Expression Vectors and MethodsGENENTECH INC·Filed 2006·Application pending·0 cites
- 2752US2014341893A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerGENENTECH INC·Filed 2014·Application pending·0 cites
- 2851US2008176257A9Assay for AntibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 2947US2006099662A1Assay for antibodiesGENENTECH INC·Filed 2005·Application pending·0 cites
- 3045US2007037254A1Expression Vectors and MethodsGENENTECH INC·Filed 2006·Application pending·0 cites
- 3143US2006177446A1Polypeptides that bind an anti-tissue factor antibody and uses thereofGENENTECH INC·Filed 2005·Application pending·0 cites
- 3240US2006067930A1Polypeptide variants with altered effector functionGENENTECH INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →